Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2014, Article ID 183852, 9 pages
http://dx.doi.org/10.1155/2014/183852
Review Article

Neoadjuvant Therapy in Pancreatic Cancer: An Emerging Strategy

AOU Ospedali Riuniti, Polytechnic University of the Marche Region, Via Conca 71, 60126 Ancona, Italy

Received 7 April 2014; Accepted 11 June 2014; Published 1 July 2014

Academic Editor: Niccola Funel

Copyright © 2014 Alessandro Bittoni et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [22 citations]

The following is the list of published articles that have cited the current article.

  • Aldona Jakštaitė, Aurelija Maziukienė, Giedrė Šilkūnienė, Antanas Gulbinas, and Žilvinas Dambrauskas, “Cugbp2 Ir Hur Baltymų Raiška Bei Funkcija Žmogaus Kasos Adenokarcinomos Patogenezėje,” Sveikatos mokslai, vol. 24, no. 6, pp. 139–143, 2014. View at Publisher · View at Google Scholar
  • John T. Miura, Ashley N. Krepline, Ben George, Paul S. Ritch, Beth A. Erickson, Fabian M. Johnston, Kiyoko Oshima, Kathleen K. Christians, Douglas B. Evans, and Susan Tsai, “Use of neoadjuvant therapy in patients 75 years of age and older with pancreatic cancer,” Surgery, 2015. View at Publisher · View at Google Scholar
  • Belfiore Maria Paola, Ronza Francesco Michele, Romano Francesco, Ianniello Giovanni Pietro, De Lucia Guido, Gallo Concetta, Marsicano Carmela, Di Gennaro Teresa Letizia, and Belfiore Giuseppe, “Percutaneous CT-guided Irreversible electroporation followed by chemotherapy as a Novel neoadjuvant protocol in locally advanced pancreatic cancer: Our preliminary experience,” International Journal of Surgery, 2015. View at Publisher · View at Google Scholar
  • Alessandro Bittoni, Kalliopi Andrikou, Andrea Lanese, Matteo Santoni, Chiara Pellei, Luca Faloppi, Michela Del Prete, Riccardo Giampieri, and Stefano Cascinu, “Treatment of pancreatic cancer. Actuality and perspective,” Recenti Progressi in Medicina, vol. 106, no. 5, pp. 208–216, 2015. View at Publisher · View at Google Scholar
  • Kezhong Tang, Wenjie Lu, Wenjie Qin, and Yulian Wu, “Neoadjuvant therapy for patients with borderline resectable pancreatic cancer: A systematic review and meta-analysis of response and resection percentages,” Pancreatology, 2015. View at Publisher · View at Google Scholar
  • Jörg Kleeff, and André L. Mihaljevicpp. 143–157, 2015. View at Publisher · View at Google Scholar
  • Jinfeng Xiang, Liang Liu, Wenquan Wang, Huaxiang Xu, Chuntao Wu, Jin Xu, Chen Liu, Jiang Long, Quanxing Ni, and Xianjun Yu, “Metabolic tumor burden: A new promising way to reach precise personalized therapy in PDAC,” Cancer Letters, 2015. View at Publisher · View at Google Scholar
  • Matthew R Zeiderman, Desiree E. Morgan, John D. Christein, William E. Grizzle, Kelly M. McMasters, and Lacey R. McNally, “Acidic pH-Targeted Chitosan-Capped Mesoporous Silica Coated Gold Nanorods Facilitate Detection of Pancreatic Tumors via Multispectral Optoacoustic Tomography,” ACS Biomaterials Science & Engineering, 2016. View at Publisher · View at Google Scholar
  • Susan M. Sharpe, and Mark S. Talamonti, “Neoadjuvant Therapy for Borderline Resectable Pancreatic Head Cancer,” Difficult Decisions in Hepatobiliary and Pancreatic Surgery, pp. 567–582, 2016. View at Publisher · View at Google Scholar
  • Kathleen K. Christians, Jonathan W. Heimler, Ben George, Paul S. Ritch, Beth A. Erickson, Fabian Johnston, Parag P. Tolat, William D. Foley, Douglas B. Evans, and Susan Tsai, “Survival of patients with resectable pancreatic cancer who received neoadjuvant therapy,” Surgery, vol. 159, no. 3, pp. 893–900, 2016. View at Publisher · View at Google Scholar
  • Iraklis Perysinakis, Chrysanthi Aggeli, Gregory Kaltsas, and George N. Zografos, “Neoadjuvant therapy for advanced pancreatic neuroendocrine tumors: an emerging treatment modality?,” Hormones, vol. 15, no. 1, pp. 15–22, 2016. View at Publisher · View at Google Scholar
  • Iraklis Perysinakis, Chrysanthi Aggeli, Gregory Kaltsas, and George N. Zografos, “Neoadjuvant therapy for advanced pancreatic neuroendocrine tumors: An emerging treatment modality?,” Hormones, vol. 15, no. 1, pp. 15–22, 2016. View at Publisher · View at Google Scholar
  • Shan-Miao Gou, Yao Liu, Chi-Dan Wan, and Yong Tang, “Clinical effectiveness of preoperative neoadjuvant chemotherapy for patients with borderline resectable pancreatic cancer: An updated meta-analysis,” Current Science, vol. 110, no. 4, pp. 595–602, 2016. View at Publisher · View at Google Scholar
  • Aleksandra Adamska, Alice Domenichini, and Marco Falasca, “Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies,” International Journal of Molecular Sciences, vol. 18, no. 7, pp. 1338, 2017. View at Publisher · View at Google Scholar
  • Ayako Furuhata, Sachiko Minamiguchi, Hiroyuki Shirahase, Yuzo Kodama, Souichi Adachi, Takaki Sakurai, and Hironori Haga, “Immunohistochemical Antibody Panel for the Differential Diagnosis of Pancreatic Ductal Carcinoma From Gastrointestinal Contamination and Benign Pancreatic Duct Epithelium in Endoscopic Ultrasound-Guided Fine-Needle Aspiration,” Pancreas, vol. 46, no. 4, pp. 531–538, 2017. View at Publisher · View at Google Scholar
  • Laura Kuhlmann, Wiebke M. Nadler, Alexander Kerner, Sabrina A. Hanke, Elisa M. Noll, Christian Eisen, Elisa Espinet, Vanessa Vogel, Andreas Trumpp, Martin R. Sprick, and Christoph P. Roesli, “Identification and Validation of Novel Subtype-Specific Protein Biomarkers in Pancreatic Ductal Adenocarcinoma,” Pancreas, vol. 46, no. 3, pp. 311–322, 2017. View at Publisher · View at Google Scholar
  • Avinash R. Kambadakone, Atif Zaheer, Ott Le, Priya Bhosale, Jeffrey Meier, Alexander R. Guimaraes, Zarine Shah, David M. Hough, Lorenzo Mannelli, Erik Soloff, Arnold Friedman, and Eric Tamm, “Multi-institutional survey on imaging practice patterns in pancreatic ductal adenocarcinoma,” Abdominal Radiology, 2017. View at Publisher · View at Google Scholar
  • Vinit Baliyan, Hamed Kordbacheh, Anushri Parakh, and Avinash Kambadakone, “Response assessment in pancreatic ductal adenocarcinoma: role of imaging,” Abdominal Radiology, 2017. View at Publisher · View at Google Scholar
  • Milan Radojkovic, Dragana Ilic, and Ivan Ilic, “Primary signet ring cell carcinoma of the pancreas with a good response to chemotherapy: Case report and literature review,” Tumori, vol. 103, pp. S50–S52, 2017. View at Publisher · View at Google Scholar
  • Savio George Barreto, and John A. Windsor, “The concept of 'borderline resectable' pancreatic cancer: Limited foundations and limited future?,” Journal of Gastrointestinal Oncology, vol. 8, no. 1, pp. 189–193, 2017. View at Publisher · View at Google Scholar
  • Savio G. Barreto, Benjamin Loveday, John A. Windsor, and Sanjay Pandanaboyana, “Detecting tumour response and predicting resectability after neoadjuvant therapy for borderline resectable and locally advanced pancreatic cancer,” ANZ Journal of Surgery, 2018. View at Publisher · View at Google Scholar
  • Sandip Basu, Rahul V. Parghane, Vikas Ostwal, and Shailesh V. Shrikhande, “Neoadjuvant strategies for advanced pancreatic neuroendocrine tumors,” Nuclear Medicine Communications, vol. 39, no. 1, pp. 94–95, 2018. View at Publisher · View at Google Scholar